Johnson and Johnson (France) Company Profile

17:40 EDT 22nd August 2014 | BioPortfolio

Our pharmaceuticals companies offer medicines that treat many of the world's most serious and widespread diseases. These diseases range from cancer, HIV/AIDS and bacterial infections to schizophrenia, epilepsy, rheumatoid arthritis and psoriasis. In 2007, we invested $5.3 billion in the search for new ways to treat these diseases and many others. It’s all part of our commitment to helping you and the ones you love lead longer, healthier lives.

These companies are organized into three global business units:

Central Nervous System and Internal Medicine

This business unit develops medicines for an array of health problems, including central nervous system disorders, such as schizophrenia and epilepsy; metabolic diseases, such as diabetes; cardiovascular diseases; and infectious diseases.

B.I.O. (Biotechnology, Immunology & Oncology)

This business unit develops traditional and biologic medicines to treat autoimmune disorders, such as rheumatoid arthritis, psoriasis, and Crohn’s disease; a wide range of cancers; and blood disorders, such as anemia.

Virology

This business unit develops medicines for the treatment of infectious diseases, such as HIV/AIDS, hepatitis C and tuberculosis.

Location

rue camille desmoulins
issy les moulineaux cedex 9
F-92787
France

Contact

Phone: 33-155004174


News Articles [1677 Associated News Articles listed on BioPortfolio]

Can Johnson & Johnson Cure What Ails Your Portfolio?

By Passive Income Pursuit:Johnson & Johnson (JNJ) is well known around the dividend growth investing community with over 50 consecutive years of dividend increases. Chances are there's Johnson &am...

Video: Johnson & Johnson Focuses on Innovation

Johnson & Johnson has unveiled a string of new equity investments and research collaborations formed by its network of new innovation centers to advance early stage programs across a broad range o...

Johnson & Johnson CEO: No Plans to Leave U.S.

Johnson & Johnson CEO Alex Gorsky joined FBN’s Maria Bartiromo to discuss the company’s second-quarter earnings.

Johnson & Johnson Professional Export is Honored to be Named Winner of the Queen's Award for Enterprise - the UK's Highest Accolade for Business Success

LONDON, April 21, 2014 /PRNewswire/ -- Today, UK-based Johnson & Johnson Professional Export, a division of Johnson & Johnson Medical Ltd, is proud to celebrate the honor of winning the Queen's Aw...

Johnson & Johnson Lifts Outlook As Q2 Results Beat View

NEW BRUNSWICK (dpa-AFX) - Healthcare giant Johnson & Johnson (JNJ) on Tuesday reported a 13 percent increase in profit for the second quarter from last year, reflecting higher sales, including str...

Why Johnson & Johnson Moved From 'Buy' To 'Hold'

author name submits:Man, wouldn't it be nice to go back in time two years and load up on Johnson & Johnson (JNJ) shares in the $60-$65 range when everyone was ragging on the company's sustained se...

The Future Of Johnson & Johnson: Growth And Stability

By Sure Dividend:The last time I analyzed Johnson & Johnson (NYSE:JNJ), they had posted strong first-quarter results with constant currency revenue rising over 5%, and international constant curre...

BRIEF-Johnson & Johnson wins reversal of $1.2 bln Risperdal judgment

March 20 (Reuters) - Johnson & Johnson : * Arkansas supreme court overturns roughly $1.2 billion judgment against

PubMed Articles [334 Associated PubMed Articles listed on BioPortfolio]

Johnson & Johnson appoints Yale project team to run data sharing scheme.

J&J partners with yale to share trial data.

Johnson & Johnson (J&J) joins GlaxoSmithKline, Pfizer, Roche, and other pharmaceutical companies in sharing its clinical trial data with researchers. J&J, however, is the only company to enlist an ind...

Late onset imatinib-induced Stevens-Johnson syndrome.

Imatinib, a BCR-ABL tyrosine kinase inhibitor, is known to cause mild to moderate cutaneous reactions in up to approximately 20% of patients. It rarely causes severe reactions, such as Stevens-Johnson...

Stevens Johnson Syndrome in a patient undergoing gynaecological brachytherapy: An association or an incident?

Stevens Johnson Syndrome and Erythema Multiforme are hypersensitivity skin reactions generally arising in the context of multiple causes. Radiation therapy is considered to be one of these causes, alt...

Evaluation of conjunctival bacterial flora in patients with Stevens-Johnson Syndrome.

To determine the conjunctival bacterial flora present in patients with Stevens-Johnson syndrome.

Clinical Trials [143 Associated Clinical Trials listed on BioPortfolio]

Stevens-Johnson Syndrome Antimicrobial

Steven-Johnson's syndrome, or great multiform erythema, appears as a systemic disturbance, with skin involvement and mucous membranes, related to several factors, such as, viral or bacteri...

Phase III Clinical Trial of NPB-01 in Patients With Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis Unresponsive to Corticosteroids.

Patients diagnosed with Stevens-Johnson syndrome and Toxic Epidermal Necrolysis were confirmed based on the investigators national diagnostic criteria. Patients who meet all inclusion crit...

Extracorporeal Photopheresis Pilot Study

ECP will be given to the patients [UVAR®XTS TM Therakos system, Johnson & Johnson] according to the following schedule: Starting at day 21 after transplant, if hematologic recovery allow...

A Relative Bioavailability Study of 20 mg Famotidine Tablets Under Fed Condition

The study was conducted as an open-label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioavailability study comparing famotidine tablets, USP 20...

A Relative Bioavailability Study of 20 mg Famotidine Tablets Under Fasting Condition

The study was conducted as an open-label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioavailability study comparing famotidine tablets, USP 20...

Companies [436 Associated Companies listed on BioPortfolio]

Johnson and Johnson

Johnson & Johnson, employing approximately 119,000 people worldwide, is engaged in the manufacture and sale of a broad range of products in the health care field in many countries of the world. Johnso...

Johnson & Johnson Innovation

The London Innovation Centre is part of Johnson & Johnson Innovation, a division of Johnson & Johnson Finance Limited. Johnson & Johnson Innovation focuses on accelerating early i...

Johnson & Johnson (China) Investment Co., Ltd.

Johnson & Johnson (China) Investment Co., Ltd. is a foreign investment entity established in China by Johnson & Johnson in 1998. For more information about Johnson & Johnson and its operating unit...

JOHNSON'S(R) Brand

JOHNSON'S® Brand from Johnson & Johnson Consumer Products Company, Division of Johnson & Johnson Consumer Companies, Inc., has a long tradition of providing pure, mild, gentle and clinically-proven p...

JANSSEN-ORTHO INC

Since 1961 Janssen-Cilag has been a member of the Johnson & Johnson family of companies. Founded in 1886, Johnson & Johnson today is the world's most comprehensive manufacturer of healthcare products...

More Information about "Johnson and Johnson (France)" on BioPortfolio

We have published hundreds of Johnson and Johnson (France) news stories on BioPortfolio along with dozens of Johnson and Johnson (France) Clinical Trials and PubMed Articles about Johnson and Johnson (France) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Johnson and Johnson (France) Companies in our database. You can also find out about relevant Johnson and Johnson (France) Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Relevant Topics

Cancer
Latest News Clinical Trials Research Drugs Reports Corporate
Cancer is a condition where cells in a specific part of the body grow and reproduce uncontrollably. The cancerous cells can invade and destroy surrounding healthy tissue, including organs.  Cancer sometimes begins in one part of the body before spre...

Psychiatry
Latest News Clinical Trials Research Drugs Reports Corporate
Psychiatry is the study of mental disorders and their diagnosis, management and prevention.  Conditions include schizophrenia, severe depression and panic disorders among others. There are pharmaceutical treatments as well as other therapies to help...

Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record